|
BRIEF-Sarepta Therapeutics Q2 **n-GAAP loss per share $1.19 excluding items
BRIEF-Sarepta Therapeutics Q2 **n-GAAP loss per share $1.19 excluding items
* ** revenue was recognized for three months ended June 30,2016 and 2015http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...mw:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...mw:F7zBnMyn0Lo http://feeds.feedburner.com/~r/reute...~4/ri_VOc6tf_Q |
| الساعة الآن 09:22 PM |
Powered by vBulletin® Copyright ©2000 - 2026, Jelsoft Enterprises Ltd. TranZ By
Almuhajir